Human papillomavirus (HPV) testing has been recently introduced as an alternative to
cytology for cervical cancer screening. However, since most HPV infections clear without …

Abstract Purpose: Human papillomavirus (HPV) DNA methylation testing is a promising
triage option for women testing HPV positive during cervical cancer screening. However, the …

Cervical neoplasia‐specific biomarkers, eg DNA methylation markers, with high sensitivity
and specificity are urgently needed to improve current population‐based screening on (pre) …

Objective triage strategies are required to prevent unnecessary referrals for colposcopy in
population‐based screening programs using primary high‐risk human papillomavirus …

Abstract Background Persistent infection with Human Papillomavirus (HPV) type 16 causes
the majority of cervical cancers. Genital HPV infection is very common, but neoplastic …

Introduction DNA methylation is proposed as a novel biomarker able to monitor molecular
events in human papillomavirus (HPV) infection pathophysiology, enabling the distinction …

Testing for high‐risk (hr) types of human papillomavirus (HPV) is highly sensitive as a
screening test of high‐grade cervical intraepithelial neoplastic (CIN2/3) disease, the …

High-risk human papillomavirus (hrHPV)-DNA testing is frequently performed parallel to
cytology for the detection of high-grade dysplasia and cervical cancer particularly in women …

Objective Testing for high risk human papillomavirus (HR-HPV) is increasing; however due
to limitations in specificity there remains a need for better triage tests. Research efforts have …

Sexually transmitted carcinogenic human papillomavirus (HPV) infections are extraordinarily
prevalent worldwide. However, most incident HPV infections clear within a few years …